Bamlanivimab
18160
Phase 2 small_molecule completed
Quick answer
Bamlanivimab for COVID-19 is a Phase 2 program (small_molecule) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- COVID-19
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed